DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Endroit courant :
>
> This Story


Ouverture ou Registre to rate this News Story
Forward Printable StoryPrint Comment

 

 

MRI Homepage

Riccardo Lattanzi National Academy of Engineering selects young MR researcher for prestigious frontiers of engineering symposium

MGH team develops a potential alternative to gadolinium-based contrast agents Made of the vital element manganese

MR imaging breaks new ground for depression and anxiety research Shows structural similarities and differences

Elekta to add functional imaging capabilities and take more time to validate MR-linac system Expects CE approval in first half of 2018

Aspect Imaging scores CE mark for its Embrace Neonatal MR system Already in use in Israel

Updated guidelines recommend use of S-ICDs for patients with ventricular arrhythmia Call to action for physicians

Study cautions against trust in MR results for axial spondyloarthritis MR scans are prone to produce positive results for axSpA in healthy individuals

Mallinckrodt Institute of Radiology installs first Siemens MAGNETOM Vida in the US First Siemens MR scanner to carry BioMatrix technology

MR study shows how different football positions impact brain damage First time DTI and fMRI used in conjunction

Action star Chuck Norris, wife Gena, sue eleven organizations over gadolinium Allege MR contrast agent 'nearly killed her'

FDA panel: Add retention warning to gadolinium contrast agents

par Thomas Dworetzky , Contributing Reporter
The gadolinium safety debate took another turn Friday, when the FDA's Medical Imaging Drugs Advisory Committee (MIDAC) voted to recommend revisions to the prescribing information for MR contrast agents with the material.

The vote was to add a warning that gadolinium can be retained in some organs and tissues.

Story Continues Below Advertisement

The (#1 Resource) for Medical Imaging and Peripherals. Call 1-949-273-8000

As a Master Distributor for major brands Barco, Philips, and Sony, we offer custom imaging solutions. With our renowned OEM Solutions and Service/Repair Center, Ampronix is a one-stop shop for HD Medical LCD Displays--Printers--Recorders--4K Cameras



According to a response to the meeting by Guerbet, “There are two kinds of gadolinium based contrast agents [GBCAs], linear and macrocyclic. Although there are many similarities amongst these agents, they differ in their kinetic and thermodynamic stability. Linear GBCAs are generally less stable, and for this reason, more likely than macrocyclic agents to deposit gadolinium in tissue. Guerbet's GBCA, Dotarem [gadoterate meglumine] is a macrocyclic agent. The advisory would also state the risk of retention is slightly greater with linear agents versus macrocyclic ones.”

At the meeting, 13 committee members voted in favor of the proposal. "It was appropriate to state that there may be differences among these agents that need to be explored," said one, Dr. Michael Weisman, a professor of medicine at the University of California, Los Angeles, adding that, "It's also appropriate to state that risk strategies need to be looked at more carefully. There are populations that need to be addressed, such as those that may overutilize this type of contrast imaging."

The strongest – and only – dissenting vote came from Alicia Toledano, who is president of Biostatistics Consulting in Kensington, MD. She felt it did not go far enough.

"It is hard to dismiss an anecdotal report when you are the anecdote. A life ruined is a life ruined," she said. "What does a patient do when doctors and everyone she or he turns to for help 'pooh-poohs' his or her concerns and does not order a simple urine test? When a patient finally gets tested and is found to have gadolinium retention, there is no FDA-approved antidote. What does that patient do?"

She called the proposal “insufficient.”



The group was also unanimous at 15-0 in its vote requiring the agency to have contrast manufacturers do more studies to see if more regulation is necessary.

The group argued that more information is vital.

"It's clear we need more information," stated Dr. Peter Herscovitch, acting MIDAC chair and director of the PET department at the U.S. National Institutes of Health (NIH).

The votes followed a public hearing on retention that saw many emotional moments about adverse reactions, including from a representative of Gena Norris, the wife of famed action-star Chuck Norris. After a series of scans with gadolinium, she suffered severe abdominal pain.

She has resorted to treating her condition with an expensive professional hyperbaric chamber.

"My heart breaks for those who don't have the financial means they need," she added. "We will continue to use our platform to raise awareness about the dangers of gadolinium."

That said, despite the risks of retention, Dr. Elizabeth Morris, past president of the Society of Breast Imaging and a breast radiologist at Memorial Sloan Kettering Cancer Center, called its use essential and a “lifesaving test."

Also advising caution against an overreaction, Dr. Scott Reeder, of the University of Wisconsin, advised that, "it is important to consider the importance of the benefits of gadolinium in treating patients with a wide variety of diseases, as well as the standard safety record of these agents."

MRI Homepage


You Must Be Logged In To Post A Comment

Publicité
Développez la notoriété de votre marque
Enchères + Ventes Privées
Obtenir le meilleur prix
Acheter des équipement / pièces
Trouver le meilleur prix
Infos du jour
Lire Les dernières nouvelles
Annuaire
Consulter tous les utilisateurs DOTmed
Éthique concernant DOTmed
Voir notre programme d'éthique
L'or partie le programme de fournisseur
Recevoir des demandes PH
Programme de marchand de service d'or
Recevoir des demandes
Fournisseurs de soins de santé
Voir tous les outils des HCP (abréviation pour les professionnels de la santé)
Les travaux/Formation
Trouver / combler un poste
Parts Hunter +EasyPay
Obtenir des devis de pièces
Certification Récentes
Voir les utilisateurs récemment certifiés
Evaluation Récentes
Voir les utilisateurs récemment certifiés
Central de location
Louer de l’équipement à moindre prix
Vendre des équipements / pièces
Obtenir le maximum d'argent
Service le forum de techniciens
Trouver de l'aide et des conseils
Simple demande de propositions
Obtenir des devis pour des appareils
Expo Virtuelle
Trouver des services d'appareils
L'Access et l'utilisation de cet emplacement est sujet aux modalités et aux conditions du notre de nos MENTIONS LEGALES & DONNEES PERSONELLES
Propriété de et classe des propriétaires DOTmedà .com, inc. Copyright ©2001-2017 DOTmed.com, Inc.
TOUS DROITS RÉSERVÉS